Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

NSE/MEDIORG stock hub

NSE/MEDIORG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/MEDIORGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

339.3M

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/MEDIORG

In the news

Latest news · NSE/MEDIORG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E7.6

P25 24.8P50 35.9P75 56.9

ROE15.2

P25 6.3P50 13.6P75 18.1

ROIC10.8

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/MEDIORG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

191

Groups with data

Currency

INR

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	114
Employees Change	52%
Employees Change Percent	83.87
Enterprise value	INR 470.9M
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	INE0PE401018
Last refreshed	2026-05-10
Market cap	INR 339.3M
Price	INR 29
Price currency	INR
Rev Per Employee	3,458,736.84x
Sector	Healthcare
Sic	2834
Symbol	nse/MEDIORG
Website	https://www.medicamenorganics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	13.48%
EV Earnings	10.3x
EV/EBIT	7.27x
EV/EBITDA	6.87x
EV/FCF	-18.13x
EV/Sales	1.19x
FCF yield	-7.65%
P/B ratio	1.03x
P/E ratio	7.55x
P/S ratio	0.86x
PE Ratio3 Y	23.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.44%
EBITDA Margin	17.4%
Gross margin	37.93%
Gross Profit	INR 149.6M
Gross Profit Growth	11.6%
Gross Profit Growth Q	24.5%
Gross Profit Growth3 Y	16.45%
Gross Profit Growth5 Y	8.54%
Net Income	INR 45.7M
Net Income Growth	79.23%
Net Income Growth Q	34.9%
Net Income Growth3 Y	20.35%
Net Income Growth5 Y	113.82%
Pretax Margin	15.17%
Profit Margin	11.6%
Profit Per Employee	INR 401,263
ROA	7.35
Roa5y	4.04
ROCE	18.6
ROE	15.17
Roe5y	11.09
ROIC	10.83
Roic5y	6.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	10.48%
EPS Growth	39.06
EPS Growth Q	15.54
EPS Growth3 Y	3.43
EPS Growth5 Y	86.54
OCF Growth5 Y	-24.44%
Revenue Growth	28.01x
Revenue Growth Q	5.91x
Revenue Growth3 Y	15.98x
Revenue Growth5 Y	4.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.72
Assets	INR 611.5M
Cash	INR 29.1M
Current Assets	INR 466.5M
Current Liabilities	INR 263.2M
Debt	INR 156.7M
Debt EBITDA	INR 2.28
Debt Equity	INR 0.47
Debt FCF	INR -6.03
Equity	INR 330.2M
Interest Coverage	10.95
Liabilities	INR 281.4M
Long Term Assets	INR 145.1M
Long Term Liabilities	INR 18.2M
Net Cash	INR -127.6M
Net Cash By Market Cap	INR -37.62
Net Debt EBITDA	INR 1.86
Net Debt Equity	INR 0.39
Tangible Book Value	INR 325M
Tangible Book Value Per Share	INR 27.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.77
Inventory Turnover	3.31
Net Working Capital	INR 327.2M
Quick ratio	1.18
Working Capital	INR 203.3M
Working Capital Turnover	INR 2.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-28.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	10.48%
200-day SMA	31.81
50-day SMA	25.3
50-day SMA vs 200-day SMA	50under200
All Time High	159.4
All Time High Change	-81.81%
All Time High Date	2024-07-02
All Time Low	19.6
All Time Low Change	47.96%
All Time Low Date	2025-03-27
ATR	1.32
Beta1y	0.88
Beta2y	0.68
Ch YTD	20.83
High	29.2
High52	49.7
High52 Date	2025-06-19
High52ch	-41.65%
Low	26.75
Low52	20.05
Low52 Date	2026-03-24
Low52ch	44.64%
Ma50ch	14.61%
Price vs 200-day SMA	-8.83%
RSI	57.52
RSI Monthly	22.14
RSI Weekly	50.63
Sharpe ratio	0.27x
Sortino ratio	0.5
Total Return	-28.87%
Tr YTD	20.83
Tr1m	13.28%
Tr1w	-0.68%
Tr3m	16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 64.8M
Operating Income Growth	11.1
Operating Income Growth Q	25.08
Operating Income Growth3 Y	17.27
Operating Income Growth5 Y	66.68
Operating margin	16.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,405,950%
Net Borrowing	27,924,000
Shares Insiders	62.34%
Shares Out	11,700,000
Shares Qo Q	0.11%
Shares Yo Y	28.87%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -26M
Average Volume	25,100x
Bv Per Share	27.85
CAPEX	INR -29.9M
Ch1m	13.28
Ch1w	-0.68
Ch1y	10.48
Ch3m	16
Ch6m	-3.65
Change	-0.68%
Change From Open	7.41
Close	29.2
Days Gap	-7.53
Depreciation Amortization	3,792,000
Dollar Volume	406,000
Earnings Date	2026-05-29
EBIT	INR 64.8M
EBITDA	INR 68.6M
EPS	INR 3.84
F Score	5
FCF	INR -26M
FCF EV Yield	-5.51x
FCF Per Share	INR -2.22
Financing CF	34,169,000
Fiscal Year End	March
Founded	1,995
Graham Number	49.05106
Graham Upside	69.14
Income Tax	INR 14.1M
Investing CF	-29,196,000
Is Primary Listing	1
Last Earnings Date	2026-02-13
Last Report Date	2025-09-30
Lynch Fair Value	INR 96
Lynch Upside	231
Ma150	28.34
Ma150ch	2.31%
Ma20	28.46
Ma20ch	1.9%
Net CF	8,874,000
Next Earnings Date	2026-05-29
Open	27
P OCF Ratio	86.96
Position In Range	91.84
Ppne	130,348,000
Price Date	2026-05-08
Price EBITDA	INR 4.95
Ptbv Ratio	1.04
Relative Volume	0.57x
Revenue	394,296,000x
Tax By Revenue	3.57x
Tax Rate	23.51%
Tr6m	-3.65%
Volume	14,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/MEDIORG pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/MEDIORG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/MEDIORG?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+62.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+28.9%

Negative means the company is buying back shares.

Technical

NSE/MEDIORG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.5

Neutral momentum band

Price vs 200-day MA

-8.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/MEDIORG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/MEDIORG stock rating?

nse/MEDIORG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/MEDIORG analysis?

The full report lives at /stocks/nse/MEDIORG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/MEDIORG?

The latest report frames nse/MEDIORG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/MEDIORG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.